Possible mechanisms in the anti-tumour activity of C. parvum
- PMID: 305375
Possible mechanisms in the anti-tumour activity of C. parvum
Abstract
Normal murine peritoneal macrophages exhibited anti-tumour cytotoxicity following simultaneous incubation with C. parvum and lymphoid cells from C. parvum-treated mice. Both T- and B-lymphocytes appear to be involved in this macrophage activation which is mediated by a soluble factor(s) released by immune lymphoid cells in response to the specific immunising strain of C. parvum. Cells capable of macrophage activation do not appear until 6 days following systemic C. parvum administration despite the appearance of cytotoxic macrophages in vivo by day 3. It was therefore concluded that two mechanisms of macrophage activation might exist (1) an early phase of activation, possibly involving a direct effect on macrophage precursors by C. parvum, and (2) a later phase in which activation is mediated by T- and B-cells responding to the C. parvum stimulus.
Similar articles
-
Alterations of host resistance to Listeria monocytogenes in tumour-bearing mice and the effect of Corynebacterium parvum.Immunology. 1981 Oct;44(2):305-10. Immunology. 1981. PMID: 7298070 Free PMC article.
-
Mechanisms of the potentiation of specific antitumor immunity by intratumor injection of Corynebacterium parvum.Cancer Res. 1983 Oct;43(10):4670-5. Cancer Res. 1983. PMID: 6883325
-
A role for T lymphocytes in the antitumour action of systemic C. parvum.Dev Biol Stand. 1977 Apr 13-15;38:253-7. Dev Biol Stand. 1977. PMID: 305374
-
Corynebacterium parvum as an immunotherapeutic anticancer agent.Semin Oncol. 1974 Dec;1(4):367-78. Semin Oncol. 1974. PMID: 4620441 Review. No abstract available.
-
On the origin and mode of action of functionally distinct macrophage subpopulations.Mol Cell Biochem. 1980 Mar 20;30(1):39-55. doi: 10.1007/BF00215304. Mol Cell Biochem. 1980. PMID: 6991911 Review. No abstract available.